Debt-to-equity of NAVIDEA BIOPHARMACEUTICALS, INC. from 31 Mar 2012 to 30 Sep 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NAVIDEA BIOPHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2023.
  • NAVIDEA BIOPHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 30 Sep 2023 was -186%, a 24% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2023 -186% +59% +24% 30 Sep 2023
Q2 2023 -182% +458% +72% 30 Jun 2023
Q1 2023 -152% -476% -147% 31 Mar 2023
Q4 2022 -177% -333% -213% 31 Dec 2022
Q3 2022 -245% -384% -276% 30 Sep 2022
Q2 2022 -640% -821% -454% 30 Jun 2022
Q1 2022 324% -296% -48% 31 Mar 2022
Q4 2021 156% +961% 31 Dec 2021
Q3 2021 139% +512% 30 Sep 2021
Q2 2021 181% +498% 30 Jun 2021
Q1 2021 621% +1692% 31 Mar 2021
Q4 2020 -805% +2122% +73% 31 Dec 2020
Q3 2020 -373% -1107% -151% 30 Sep 2020
Q2 2020 -317% -774% -170% 30 Jun 2020
Q1 2020 -1072% -1559% -320% 31 Mar 2020
Q4 2019 -2926% -3253% -995% 31 Dec 2019
Q3 2019 734% +550% +299% 30 Sep 2019
Q2 2019 456% +352% +337% 30 Jun 2019
Q1 2019 487% +409% +523% 31 Mar 2019
Q4 2018 327% +274% +518% 31 Dec 2018
Q3 2018 184% +918% 30 Sep 2018
Q2 2018 104% +290% 30 Jun 2018
Q1 2018 78% +214% 31 Mar 2018
Q4 2017 53% +170% 31 Dec 2017
Q3 2017 -734% -615% -518% 30 Sep 2017
Q2 2017 -185% -63% -51% 30 Jun 2017
Q1 2017 -136% -5% -3.8% 31 Mar 2017
Q4 2016 -117% +17% +13% 31 Dec 2016
Q3 2016 -119% +19% +14% 30 Sep 2016
Q2 2016 -123% +21% +15% 30 Jun 2016
Q1 2016 -131% +22% +14% 31 Mar 2016
Q4 2015 -134% +52% +28% 31 Dec 2015
Q3 2015 -137% +117% +46% 30 Sep 2015
Q2 2015 -143% +393% +73% 30 Jun 2015
Q1 2015 -153% +1276% +89% 31 Mar 2015
Q4 2014 -186% -44923% -100% 31 Dec 2014
Q3 2014 -255% -3825% -107% 30 Sep 2014
Q2 2014 -536% +1759% +77% 30 Jun 2014
Q1 2014 -1429% -2021% -342% 31 Mar 2014
Q4 2013 44737% +44566% +26121% 31 Dec 2013
Q3 2013 3570% +3486% +4123% 30 Sep 2013
Q2 2013 -2295% -2342% -4959% 30 Jun 2013
Q1 2013 592% +548% +1249% 31 Mar 2013
Q4 2012 171% 31 Dec 2012
Q3 2012 85% 30 Sep 2012
Q2 2012 47% 30 Jun 2012
Q1 2012 44% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.